原田 介斗

Harada Kaito

  • 助教
  • 学位:博士(医学)

基本情報

所属

  • Undergraduate School of Medicine / Faculty of Medicine

詳細情報

研究キーワード

  • graft failure

研究分野

  • Life sciences Hematology and oncology

受賞

  • 67th ASH annual meeting annual meeting abstract achievement award, 2025
  • Japanese Society for Hematology encouragement award, 2021
  • Japanese Society for Transplantation and Cellular Therapy Working Group Research Award, 2020

論文

Cord blood versus bone marrow/peripheral blood stem cell transplantation under reduced-intensity conditioning in high-risk acute myeloid leukemia and myelodysplastic syndromes.

MicroRNA-142 improves IL1RAP CAR-T cell activity in acute myeloid leukemia

Successful Treatment of Chronic Active Epstein-Barr Virus Infection Complicated by Cardiomyopathy in an Adult Patient

Comparison of Nonrelapse Mortality After Haploidentical Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation in Hematologic Disease.

Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A Kanto Study Group for Cell Therapy multicenter analysis

Pre-emptive and prophylactic donor lymphocyte infusion following allogeneic stem cell transplantation

Mitochondrial Electron Transport Chain Complex II Dysfunction Causes Premature Aging of Hematopoietic Stem Cells

Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection

Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults

Outcomes of salvage haploidentical transplantation using posttransplant cyclophosphamide for graft failure following allogeneic hematopoietic stem cell transplantation

Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia

Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation.

Plasminogen activator inhibitor type-1 is a negative regulator of hematopoietic regeneration in the adipocyte-rich bone marrow microenvironment

Comparison of immunosuppressant regimens in salvage cord blood transplantation for graft failure after allogeneic hematopoietic stem cell transplantation

Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation

Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation

The effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantation

Cytomegalovirus meningitis in a patient with relapsed acute myeloid leukemia

Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning

Clinical impact of underweight status at diagnosis on elderly patients with acute myeloid leukemia: a retrospective study of JALSG GML200

Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201

Outcomes after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia harboring t(7;11)(p15;p15)

Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation

Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation

Clinical utility of high‑flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematological disease

講演・口頭発表等

  • MicroRNA-142 Improves IL1RAP CAR-T Cell Activity in Acute Myeloid Leukemia
  • The Efficacy of Cord Blood Transplantation Using Ultra-Low-Dose Methotrexate for High-Risk AML/MDS
  • Comparison of Non-Relapse Mortality after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation for Hematologic Disease
  • Haploidentical Salvage Transplantation Using PTCy for Graft Failure Following allogeneic HSCT
  • Mitochondrial complex II dysfunction leads to hematopoietic stem cell aging and myelodysplastic syndrome
  • 同種移植後インフルエンザウイルス感染症 KSGCT多施設共同二次調査研究(Influenza virus infection after hematopoietic stem cell transplantation: a KSGCT multicenter survey)
  • Mitochondrial complex II dysfunction leads to hematopoietic stem cell aging and myelodysplastic syndrome
  • Mitochondrial electron transport chain complex II dysfunction drives premature aging of hematopoietic stem cells
  • Haploidentical and cord blood salvage transplantation for graft failure after allogeneic hematopoietic stem cell transplantation
  • The effect of melphalan dose as reduced-intensity conditioning for acute lymphoblastic leukemia
  • Risk stratification and prognosticators of acute myeloid leukemia with myelodysplasia-related changes patients undergoing allogeneic stem cell transplantation
  • Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning
  • t(7;11)(p15;p15)を有する急性骨髄性白血病の同種移植成績
  • Clinical impact of body-mass index on the outcome of Japanese patients with acute myeloid leukemia
  • Clinical impact of underweight on the outcome of patients with acute myeloid leukemia: Retrospective study of JALSG AML201
  • Retrospective Evaluation of Incidence and Prognostic Factors for Stenotrophomonas Maltophilia Bacteremia Following Allogeneic Hematopoietic Stem Cell Transplantation
  • Bone marrow Adipocyte-derived PAI-1 as a Negative Regulator of Hematopoietic Regeneration

共同研究・競争的資金等の研究課題

Supportive role of regulatory T cells on chronic myeloid leukemia stem cells

The mechanism of impaired hematopoietic regeneration by bone marrow adipocytes

ResearchMapへ移動します

Contact Us

Inquiries about coverage

Public Affairs Division Public Affairs and Communications Department

Tel. 0463-63-4670(direct dialing)